Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Share-based Compensation: 2010-2025

Historic Share-based Compensation for Mesa Laboratories (MLAB) over the last 16 years, with Sep 2025 value amounting to $3.8 million.

  • Mesa Laboratories' Share-based Compensation fell 0.65% to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.1 million, marking a year-over-year increase of 12.11%. This contributed to the annual value of $13.1 million for FY2025, which is 10.10% up from last year.
  • Per Mesa Laboratories' latest filing, its Share-based Compensation stood at $3.8 million for Q3 2025, which was down 1.78% from $3.9 million recorded in Q2 2025.
  • Over the past 5 years, Mesa Laboratories' Share-based Compensation peaked at $4.4 million during Q3 2022, and registered a low of $2.0 million during Q3 2021.
  • Moreover, its 3-year median value for Share-based Compensation was $3.1 million (2025), whereas its average is $3.2 million.
  • Its Share-based Compensation has fluctuated over the past 5 years, first spiked by 1,007.44% in 2021, then plummeted by 44.48% in 2022.
  • Mesa Laboratories' Share-based Compensation (Quarterly) stood at $3.7 million in 2021, then crashed by 44.48% to $2.1 million in 2022, then surged by 45.57% to $3.0 million in 2023, then climbed by 8.22% to $3.2 million in 2024, then decreased by 0.65% to $3.8 million in 2025.
  • Its last three reported values are $3.8 million in Q3 2025, $3.9 million for Q2 2025, and $3.1 million during Q1 2025.